Background Heparin-induced thrombocytopenia (HIT) is a relatively uncommon condition
characterized by two exceedingly common phenomena in hospitalized patients …

Establishing the diagnosis of heparin induced thrombocytopenia (HIT) is challenging as
laboratory tests for HIT vary in specificity and availability. As HIT suspicion far exceeds …

Background Despite the availability of clinical practice guidelines (CPGs), the risk of death
or thromboembolic complication associated with heparin-induced thrombocytopenia (HIT) …

Purpose. An evidence-based heparin-induced thrombocytopenia (HIT) treatment protocol to
standardize the management of confirmed or suspected HIT was developed. Summary. In a …

Heparin-induced thrombocytopenia (HIT) is a" clinical-pathological" syndrome (1, 2). This
means that to diagnose HIT a patient must both exhibit a clinical picture compatible with this …

Heparin-induced thrombocytopenia (HIT) is a prothrombotic adverse drug reaction occurring
in< 0.1% to 7% of patients receiving heparin products depending on the patient population …

Purpose Heparin-induced thrombocytopenia (HIT) is a serious complication of heparin
administration. Management strategies are complex and include discontinuing heparin …

In October 2013, we implemented a hemostatic and antithrombotic (HAT) stewardship
program with the primary focus of ensuring appropriate use of intravenous direct thrombin …

Patients with heparin-induced thrombocytopenia (HIT) are at high risk of thrombosis and
should be treated with alternative anticoagulant therapy to reduce complications. The …

Heparin-induced thrombocytopenia (HIT, type II) is an immune-mediated disorder due to
antibodies formed against heparin–platelet factor 4 complexes, usually appearing at days 5 …